gene therapy

3+ articles

AI in biotechnology David Baker Jeff Bezos POSTECH Retro Biosciences

Tech Moguls Bankrolling the Race Against Time: Can Cash Combat Aging?

The article from Business Insider delves into the burgeoning scene of tech billionaires heavily investing in biotechnology aimed at extending human lifespans. These big-name investors, including Sam Altman, Jeff Bezos, and Sergey Brin, are backing innovative startups like Retro Biosciences, focused on anti-aging technologies. The piece explores not only the motivations behind these investments but also the ethical, economic, and social implications of potentially lengthening human life.

Sep 14

Tech Moguls Bankrolling the Race Against Time: Can Cash Combat Aging?

NGNE: Biotech Stock Buzzes with Recovery Signals!

Neurogene Inc. (NGNE) is making headlines with newfound technical indicators pointing to a bullish recovery phase. After a consolidated stagnation, chart watchers are ecstatic over moving averages and momentum signals suggesting an upward price trajectory. But does this spell a true recovery for this biotech innovator, or are risks still on the horizon? Dive into the technical intricacies and see if NGNE's comeback is here to stay.

Aug 24

NGNE: Biotech Stock Buzzes with Recovery Signals!

AI-Designed Protein Nanocages: A Game Changer for Gene Therapy

AI-designed protein nanocages are set to revolutionize the field of gene therapy by mimicking viral structures to carry more genetic material than current methods. This groundbreaking innovation from POSTECH, in collaboration with David Baker, offers newfound hope in treating genetic conditions and marks a significant leap in biotechnology. The versatile forms of these nanocages, confirmed by electron microscopy, demonstrated successful therapeutic payload delivery, opening doors to next-gen vaccines and beyond.

Dec 25

AI-Designed Protein Nanocages: A Game Changer for Gene Therapy